ATGE vs PSMT

ATGE's deterministic health score is concerning with a Piotroski F-Score of 4/9, indicating marginal financial stability, while the absence of an Altman Z-Score prevents a full distress risk assessment. The company demonstrates strong profitability and growth, with robust earnings surprises and high ROE, but faces headwinds from a bearish technical trend and weak liquidity ratios. Valuation is mixed: trading below analyst target of $158.25 but above the conservative Graham Number of $76.73, reflecting premium pricing for growth. Despite solid fundamentals and sector outperformance in ROE and margins, the lack of insider activity and near-term technical weakness temper bullishness.

PSMT exhibits a stable but mediocre financial health profile with a Piotroski F-Score of 4/9 and a Graham Number of $71.11, indicating the stock is currently trading at a significant premium. While the company maintains a very healthy Debt/Equity ratio (0.24) and consistent revenue growth (~9.7%), the current price of $161.78 far exceeds both the Graham Number and the growth-based Intrinsic Value of $123.95. Bearish insider activity and thin profit margins (2.82%) offset the strong 1-year price momentum, suggesting the stock may be overextended.